Cellular Insights Series: Unlocking Cancer Insights with Extracellular Vesicles in Liquid Biopsy

About This Series

Wiley and the American Society for Cell Biology (ASCB) are excited to present a new dynamic webinar series spotlighting cutting-edge advances in cell biology, leading up to the highly anticipated Cell Bio 2025 annual meeting.

This series brings together leading voices in cancer research, stem cell biology, and advanced imaging to spark discussion, share innovation, and provide researchers with actionable insights that can accelerate their work. Whether you are investigating fundamental cellular mechanisms or driving translational applications, this series offers valuable perspectives for the entire biological sciences community.

Why should you attend:

• Gain first-hand insights from leading researchers and opinion leaders discussing breakthroughs in cancer biology, stem cells, imaging platforms, and translational applications.
• Explore the latest findings on extracellular vesicles (EVs) in cancer research and their potential as transformative biomarkers for early detection, diagnosis, and monitoring through liquid biopsy approaches.
• Learn how advances in optical and nanoplasmonic sensing are redefining sensitivity, reproducibility, and scalability in single EV analysis.
• See real-world demonstrations of next-generation technologies designed to enhance research outcomes and streamline biological discovery.
• Connect with a global community of scientists across disciplines and participate in conversations that shape the future of cell biology.

Extracellular vesicles (EVs)—nanoscale, cell-derived structures rich in proteins and nucleic acids—are emerging as powerful circulating biomarkers that capture the molecular fingerprints of tumors. Despite their promise, translating EV research into clinical practice faces a major hurdle: developing sensitive and standardized tools capable of dissecting EV composition and molecular signatures from complex clinical samples, ideally at the single-vesicle level.

In this webinar, Prof. Im presents a breakthrough nanoplasmonic sensing platform engineered for single EV capture and multiplexed protein and RNA profiling. By harnessing plasmonic signal amplification, this approach achieves superior detection sensitivity without the need for chemical or enzymatic amplification steps—resulting in faster, more reproducible analyses. Clinical studies applying this technology to ovarian, pancreatic, and cholangiocarcinoma samples have already demonstrated high accuracy in cancer detection and treatment monitoring.

By integrating nanoplasmonics with liquid biopsy, this innovation brings us closer to robust, clinically translatable tools for precision oncology and beyond.

This event is sponsored by Oxford Instruments. Discover Oxford Instruments' advanced portfolio of fluorescence microscopy solutions, designed to support cutting-edge research in cancer studies, here.

*A Certificate of Attendance will be sent to participants who attend the webinar live*